These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22430083)

  • 21. Hematopoietic stem cell transplantation for inborn errors of metabolism: A report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Kato S; Yabe H; Takakura H; Mugishima H; Ishige M; Tanaka A; Kato K; Yoshida N; Adachi S; Sakai N; Hashii Y; Ohashi T; Sasahara Y; Suzuki Y; Tabuchi K
    Pediatr Transplant; 2016 Mar; 20(2):203-14. PubMed ID: 26806759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study.
    Miyamoto S; Umeda K; Kurata M; Nishimura A; Yanagimachi M; Ishimura M; Sato M; Shigemura T; Kato M; Sasahara Y; Iguchi A; Koike T; Takahashi Y; Kajiwara M; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
    J Clin Immunol; 2021 Nov; 41(8):1865-1877. PubMed ID: 34448087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
    Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
    Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2).
    Wadhwa A; Chen Y; Holmqvist A; Wu J; Ness E; Parman M; Kung M; Hageman L; Francisco L; Braunlin E; Miller W; Lund T; Armenian S; Arora M; Orchard P; Bhatia S
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):328-334. PubMed ID: 30292746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?
    Fernandes JF; Rocha V; Labopin M; Neven B; Moshous D; Gennery AR; Friedrich W; Porta F; Diaz de Heredia C; Wall D; Bertrand Y; Veys P; Slatter M; Schulz A; Chan KW; Grimley M; Ayas M; Gungor T; Ebell W; Bonfim C; Kalwak K; Taupin P; Blanche S; Gaspar HB; Landais P; Fischer A; Gluckman E; Cavazzana-Calvo M;
    Blood; 2012 Mar; 119(12):2949-55. PubMed ID: 22308292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.
    Hoenig M; Lagresle-Peyrou C; Pannicke U; Notarangelo LD; Porta F; Gennery AR; Slatter M; Cowan MJ; Stepensky P; Al-Mousa H; Al-Zahrani D; Pai SY; Al Herz W; Gaspar HB; Veys P; Oshima K; Imai K; Yabe H; Noroski LM; Wulffraat NM; Sykora KW; Soler-Palacin P; Muramatsu H; Al Hilali M; Moshous D; Debatin KM; Schuetz C; Jacobsen EM; Schulz AS; Schwarz K; Fischer A; Friedrich W; Cavazzana M;
    Blood; 2017 May; 129(21):2928-2938. PubMed ID: 28331055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.
    Hassan A; Booth C; Brightwell A; Allwood Z; Veys P; Rao K; Hönig M; Friedrich W; Gennery A; Slatter M; Bredius R; Finocchi A; Cancrini C; Aiuti A; Porta F; Lanfranchi A; Ridella M; Steward C; Filipovich A; Marsh R; Bordon V; Al-Muhsen S; Al-Mousa H; Alsum Z; Al-Dhekri H; Al Ghonaium A; Speckmann C; Fischer A; Mahlaoui N; Nichols KE; Grunebaum E; Al Zahrani D; Roifman CM; Boelens J; Davies EG; Cavazzana-Calvo M; Notarangelo L; Gaspar HB;
    Blood; 2012 Oct; 120(17):3615-24; quiz 3626. PubMed ID: 22791287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-center study of hematopoietic stem cell transplantation for primary immune deficiencies (PIDD).
    Dinardo L; Brown V; Perez E; Bunin N; Sullivan KE
    Pediatr Transplant; 2012 Feb; 16(1):63-72. PubMed ID: 22093026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
    Straathof KC; Rao K; Eyrich M; Hale G; Bird P; Berrie E; Brown L; Adams S; Schlegel PG; Goulden N; Gaspar HB; Gennery AR; Landais P; Davies EG; Brenner MK; Veys PA; Amrolia PJ
    Lancet; 2009 Sep; 374(9693):912-20. PubMed ID: 19729196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor.
    Ringden O; Remberger M; Gustafsson B; Moretti G; Mattsson J; Winiarski J; Sadeghi B
    Transplantation; 2019 Jun; 103(6):1247-1252. PubMed ID: 30300286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Krance RA; Paul ME; Abramson SL; Noroski LM; Davis CM; Seeborg FO; Foster SB; Leung KS; Brown BS; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2009 Nov; 124(5):1062-9.e1-4. PubMed ID: 19895994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell transplantation in primary immunodeficiency disease patients.
    Sato T; Kobayashi R; Toita N; Kaneda M; Hatano N; Iguchi A; Kawamura N; Ariga T
    Pediatr Int; 2007 Dec; 49(6):795-800. PubMed ID: 18045274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
    Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
    Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders.
    Burroughs LM; Storb R; Leisenring WM; Pulsipher MA; Loken MR; Torgerson TR; Ochs HD; Woolfrey AE
    Bone Marrow Transplant; 2007 Oct; 40(7):633-42. PubMed ID: 17660844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.
    Duncan CN; Majhail NS; Brazauskas R; Wang Z; Cahn JY; Frangoul HA; Hayashi RJ; Hsu JW; Kamble RT; Kasow KA; Khera N; Lazarus HM; Loren AW; Marks DI; Maziarz RT; Mehta P; Myers KC; Norkin M; Pidala JA; Porter DL; Reddy V; Saber W; Savani BN; Schouten HC; Steinberg A; Wall DA; Warwick AB; Wood WA; Yu LC; Jacobsohn DA; Sorror ML
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):151-8. PubMed ID: 25316109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning.
    Veys P; Rao K; Amrolia P
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S45-7. PubMed ID: 15812530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
    Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
    Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.
    Nishimura A; Aoki Y; Ishiwata Y; Ichimura T; Ueyama J; Kawahara Y; Tomoda T; Inoue M; Matsumoto K; Inoue K; Hiroki H; Ono S; Yamashita M; Okano T; Tanaka-Kubota M; Ashiarai M; Miyamoto S; Miyawaki R; Yamagishi C; Tezuka M; Okawa T; Hoshino A; Endo A; Yasuhara M; Kamiya T; Mitsuiki N; Ono T; Isoda T; Yanagimachi M; Tomizawa D; Nagasawa M; Mizutani S; Kajiwara M; Takagi M; Kanegane H; Imai K; Morio T
    J Clin Immunol; 2021 Jul; 41(5):944-957. PubMed ID: 33527309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.